Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rosemarie Mick

Showing results (41-50 of 119) with videos related to

Pageof 12
Sort By:
Cancer Research|May 8, 2007
Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavirZibin Jiang, Nabendu Pore, George J Cerniglia, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2016
A Prospective Study of Proton Beam Reirradiation for Esophageal CancerAnnemarie Fernandes, Abigail T Berman, Rosemarie Mick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigenHiral Patel, Rosemarie Mick, Jarod Finlay, et al.
Annals of Surgical Oncology|July 16, 2013
Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCISMegan Fracol, Shuwen Xu, Rosemarie Mick, et al.
The Annals of Thoracic Surgery|March 21, 2003
A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesotheliomaJoseph S Friedberg, Rosemarie Mick, James Stevenson, et al.
Plos One|December 24, 2011
Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responsesCheryl Lai-Lai Chiang, Andrea R Hagemann, Rachel Leskowitz, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2005
Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patientsEmma E Furth, Jian Li, Enkhtsetseg Purev, et al.
Journal of Surgical Oncology|May 11, 2011
The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive diseaseShuko Harada, Rosemarie Mick, Robert E Roses, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastasesEugene A Choi, Hanqin Lei, David J Maron, et al.
Cancer|November 27, 2014
A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancerPenny Fang, Rosemarie Mick, Curtiland Deville, et al.
Pageof 12

Showing results (41-50 of 119) with videos related to

Sort By:
Pageof 12
Cancer Research|May 8, 2007
Phosphatase and tensin homologue deficiency in glioblastoma confers resistance to radiation and temozolomide that is reversed by the protease inhibitor nelfinavirZibin Jiang, Nabendu Pore, George J Cerniglia, et al.
International Journal of Radiation Oncology, Biology, Physics|February 6, 2016
A Prospective Study of Proton Beam Reirradiation for Esophageal CancerAnnemarie Fernandes, Abigail T Berman, Rosemarie Mick, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 5, 2008
Motexafin lutetium-photodynamic therapy of prostate cancer: short- and long-term effects on prostate-specific antigenHiral Patel, Rosemarie Mick, Jarod Finlay, et al.
Annals of Surgical Oncology|July 16, 2013
Response to HER-2 pulsed DC1 vaccines is predicted by both HER-2 and estrogen receptor expression in DCISMegan Fracol, Shuwen Xu, Rosemarie Mick, et al.
The Annals of Thoracic Surgery|March 21, 2003
A phase I study of Foscan-mediated photodynamic therapy and surgery in patients with mesotheliomaJoseph S Friedberg, Rosemarie Mick, James Stevenson, et al.
Plos One|December 24, 2011
Day-4 myeloid dendritic cells pulsed with whole tumor lysate are highly immunogenic and elicit potent anti-tumor responsesCheryl Lai-Lai Chiang, Andrea R Hagemann, Rachel Leskowitz, et al.
Cancer Immunology, Immunotherapy : CII|July 22, 2005
Serum antibodies to EpCAM in healthy donors but not ulcerative colitis patientsEmma E Furth, Jian Li, Enkhtsetseg Purev, et al.
Journal of Surgical Oncology|May 11, 2011
The significance of HER-2/neu receptor positivity and immunophenotype in ductal carcinoma in situ with early invasive diseaseShuko Harada, Rosemarie Mick, Robert E Roses, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 24, 2004
Combined 5-fluorouracil/systemic interferon-beta gene therapy results in long-term survival in mice with established colorectal liver metastasesEugene A Choi, Hanqin Lei, David J Maron, et al.
Cancer|November 27, 2014
A case-matched study of toxicity outcomes after proton therapy and intensity-modulated radiation therapy for prostate cancerPenny Fang, Rosemarie Mick, Curtiland Deville, et al.
Pageof 12